News in early breast cancer this year was marked by updated U.S. Preventive Services Task Force (USPSTF) screening ...

In the US, five-year relative survival rates now exceed 91% ... removing hormonal sources could block breast cancer growth, paving the way for hormone therapy. In the 1940s, radiation therapy ...

Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, ...

2 By comparison, the aggregate 5-year survival is 97% for prostate cancer, 91% for breast ... rates of cancer are growing among people not covered by current screening guidelines. On the plus ...

Rifampin, phenytoin and carbamazepine should be avoided with ribociclib therapy ... improves survival in post-menopausal women with hormone receptor-positive metastatic breast cancer.

The 1-year relative survival rate for all cancers combined fell from 82.3% in the second quarter of 2018 to 77.5% in the second quarter of 2020. The COVID-19 pandemic reduced survival in US cancer ...

After chemotherapy failure, if the cancer is also resistant to endocrine therapy ... oncologist's choice can directly affect survival outcomes. HER2-low breast cancer does not overexpress the ...

One year ago, the rate on the 15-year fixed note averaged 6.81%. Get a brief on the top business stories of the week, plus CEO interviews, market updates, tech and money news that matters to you.

Researchers also are trying to understand the racial disparities in breast cancer diagnosis and mortality. Black women have a lower survival rate for breast cancer than white women, no matter the ...

It extends an uptick in mortgage rates despite expected Federal Reserve rate cuts. Source: Freddie Mac By The New York Times By Danielle Kaye Mortgage rates jumped this week as investors processed ...